Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Surg.

Sec. Reconstructive and Plastic Surgery

Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1679998

This article is part of the Research TopicSurgical Innovations in the Management of Chronic WoundsView all 3 articles

Type 3A Free Anterolateral Thigh Chimeric Flap Based on the Zunyi Classification for Reconstructing Diabetic Foot wounds

Provisionally accepted
Tianhua  ZhangTianhua ZhangXiangkui  WuXiangkui WuLingli  JiangLingli JiangShun'e  XiaoShun'e XiaoHai  LiHai LiWei  ChenWei ChenShusen  ChangShusen ChangBihua  WuBihua WuZairong  WeiZairong WeiChengliang  DengChengliang Deng*
  • Affiliated Hospital of Zunyi Medical University, Zunyi, China

The final, formatted version of the article will be published soon.

Background: Diabetic foot wounds (DFWs) often present with multilayered tissue loss involving skin, fascia, muscle, and neurovascular structures, posing substantial reconstructive challenges. The Zunyi Classification provides a function-oriented framework for chimeric anterolateral thigh (ALT) flap design. This study aimed to evaluate the clinical efficacy of the Zunyi Type 3A chimeric ALT flap in the reconstruction of complex DFWs. Methods: A retrospective cohort study was carried out involving 28 patients with Wagner grade 2-4 DFWs who underwent reconstruction using a Zunyi Type 3A chimeric ALT flap between June 2021 and June 2024. All flaps were designed based on a single perforator without skin paddle segmentation. Flap composition was tailored to defect characteristics, incorporating combinations of skin, fascia lata, muscle, and sensory nerve. Primary outcomes included flap survival, complication rate, donor-site morbidity, and long-term functional outcome. Results: Among the 28 patients with Wagner grade 2-4 DFWs, the most common flap composition was skin + fascia lata + muscle (S+F+M), applied in 17 cases (60.7%). This was followed by skin + muscle + sensory nerve (S+M+N) in 6 cases (21.4%) and skin + fascia lata + sensory nerve (S+F+N) in 5 cases (17.9%). Flap survival was excellent, with 96.4% demonstrating complete viability; one case of partial distal necrosis was managed successfully with debridement and skin grafting. No donor-site complications were observed. During a median follow-up of 13 months (range: 3-30), none of the patients had ulcer recurrence, major infection, or limb-threatening events occurred. Most patients regained satisfactory ambulatory function while preserving limb integrity. Conclusions: The Zunyi Type 3A chimeric ALT flap offers a reliable, adaptable solution for limb salvage in patients with advanced DFWs. Its capacity to incorporate multiple tissue types in a single, unsegmented design offers effective coverage, structural support, and long-term durability. These findings support broader clinical application of the Zunyi Classification in personalized reconstructive strategies for complex DFWs.

Keywords: Diabetic foot wounds (DFWs), Anterolateral thigh flap (ALT), Zunyi Classification, Type 3A chimeric flap, Limb Salvage, Microsurgical reconstruction, Multitissue defects, functional outcome

Received: 05 Aug 2025; Accepted: 16 Oct 2025.

Copyright: © 2025 Zhang, Wu, Jiang, Xiao, Li, Chen, Chang, Wu, Wei and Deng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Chengliang Deng, cheliadeng@sina.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.